GLORY HEALTH IND. HD-001 (F:84R) — Stock Price
GLORY HEALTH IND. HD-001 (F:84R) is currently trading at €0.01 EUR, up 11.11% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.02. This page tracks GLORY HEALTH IND. HD-001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 84R company net worth.
GLORY HEALTH IND. HD-001 (84R) Stock Price Chart — Daily History & Trading Volume
The chart below tracks GLORY HEALTH IND. HD-001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
GLORY HEALTH IND. HD-001 Income Statement — Revenue, Profit & Earnings by Year
GLORY HEALTH IND. HD-001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €1.04 Billion | €2.71 Billion | €2.51 Billion | €3.90 Billion | €9.90 Billion |
| Cost of Revenue | €1.34 Billion | €2.15 Billion | €2.56 Billion | €3.79 Billion | €8.65 Billion |
| Gross Profit | €-308.09 Million | €555.56 Million | €-50.28 Million | €113.52 Million | €1.25 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | €243.61 Million | €277.35 Million | €406.71 Million | €460.57 Million | €667.52 Million |
| Total Operating Expenses | €1.59 Billion | €2.43 Billion | €2.96 Billion | €4.25 Billion | €9.32 Billion |
| Operating Income | €-551.70 Million | €278.21 Million | €-456.99 Million | €-347.05 Million | €579.71 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €847.34 Million | €1.00 Billion | €502.67 Million | €451.59 Million | €744.91 Million |
| Income Before Tax | €-1.90 Billion | €-1.44 Billion | €-655.46 Million | €-1.09 Billion | €876.87 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-1.82 Billion | €-1.24 Billion | €-563.97 Million | €-912.78 Million | €228.33 Million |
GLORY HEALTH IND. HD-001 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes GLORY HEALTH IND. HD-001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €54.19 Billion | €57.20 Billion | €56.35 Billion | €57.39 Billion | €61.07 Billion |
| Total Current Assets | €28.91 Billion | €32.37 Billion | €29.72 Billion | €31.22 Billion | €35.14 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | €291.23 Million | €295.22 Million | €226.05 Million | €1.43 Billion | €502.29 Million |
| Inventory | €20.22 Billion | €20.91 Billion | €22.18 Billion | €24.23 Billion | €26.15 Billion |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €43.59 Billion | €44.83 Billion | €42.57 Billion | €43.01 Billion | €45.64 Billion |
| Total Current Liabilities | €28.83 Billion | €31.31 Billion | €29.65 Billion | €31.32 Billion | €29.64 Billion |
| Long-term Debt | €12.55 Billion | €11.23 Billion | €10.57 Billion | €9.09 Billion | €13.32 Billion |
| Net Debt | €23.77 Billion | €22.72 Billion | €22.10 Billion | €21.12 Billion | €20.48 Billion |
| Total Stockholder Equity | €8.11 Billion | €9.93 Billion | €11.17 Billion | €11.73 Billion | €12.71 Billion |
| Retained Earnings | €6.26 Billion | €8.08 Billion | €9.32 Billion | €9.89 Billion | — |
GLORY HEALTH IND. HD-001 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how GLORY HEALTH IND. HD-001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €75.05 Million | €679.53 Million | €512.92 Million | €606.31 Million | €4.35 Billion |
| Capital Expenditures | €21.61 Million | €1.27 Million | €60.81 Million | €192.85 Million | €279.54 Million |
| Free Cash Flow | €53.44 Million | €678.26 Million | €452.11 Million | €413.47 Million | €4.07 Billion |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €51.12 Million | €80.87 Million | €83.49 Million | €96.27 Million | €92.67 Million |
| Change in Cash | €-23.32 Million | €-4.25 Million | €-55.52 Million | €-330.00 Million | €-1.12 Billion |
GLORY HEALTH IND. HD-001 Earnings History — EPS Actual vs. Analyst Estimates
Track GLORY HEALTH IND. HD-001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2025 | — | — | — |